Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the GRADE clinical trial showed.

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

Discover if this celebrity-backed supplement truly helps with hunger control, fat reduction, and weight management.

The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people ... but the improvements in brain volume and cognitive function were statistically significant.

Columnist Jen Cueva talks with her friend Lynda Pinto, who has PH, about Lynda's experience with GLP-1 agonist medications.

“Fructo-oligosaccharides (FOS) are prebiotic fibers that have a significant impact on the secretion and function of the ...